Fred Alger Management’s Veracyte VCYT Stock Holding History

Fred Alger Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.9M	Sell	321,311 -258,149	-45%	-$10.8M	0.06%	118
2026 Q1	$18.7M	Sell	579,460 -54,434	-9%	-$2.01M	0.08%	118
2025 Q4	$26.7M	Sell	633,894 -133,585	-17%	-$5.38M	0.1%	95
2025 Q3	$26.3M	Buy	+767,479	New	+$22M	0.1%	102
2025 Q1	–	Sell	-33,892	Closed	-$1.34M	–	478
2024 Q4	$1.34M	Buy	33,892 +24,321	+254%	+$921K	0.01%	355
2024 Q3	$326K	Buy	+9,571	New	+$269K	﹤0.01%	393
2022 Q3	–	Sell	-12,943	Closed	-$258K	–	567
2022 Q2	$258K	Buy	+12,943	New	+$261K	﹤0.01%	422

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fred Alger Management's VCYT Position: Q2 2026 in Review

Fred Alger Management reduced its Veracyte (VCYT) stake by 45% in Q2 2026, selling an estimated $10.8M and leaving 321,311 shares worth $18.9M. The position accounts for 0.06% of the portfolio, ranked #118.

Fred Alger Management first reported a position in VCYT in Q2 2022 and has held it in 7 quarters since. The position peaked at $26.7M in Q4 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Fred Alger Management held 321,311 shares of Veracyte worth $18.9M as of Q2 2026.
Fred Alger Management sold 258,149 Veracyte shares in Q2 2026, an estimated $10.8M.
Veracyte made up 0.06% of Fred Alger Management's portfolio in Q2 2026, its #118 holding.
Fred Alger Management first reported a position in Veracyte in Q2 2022 and has held it in 7 quarters since.
Fred Alger Management's Veracyte position peaked at $26.7M in Q4 2025.
370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.